IGF-I secretion by prostate carcinoma cells does not alter tumor-bone cell interactions in vitro or in vivo

Janet Rubin, Xian Fan, Jill Rahnert, Buer Sen, Chia Ling Hsieh, Tamara C. Murphy, Mark S. Nanes, Lindsay G. Horton, Wesley G. Beamer, Clifford J. Rosen

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

BACKGROUND. IGF-I is an important growth and differentiative factor for osteoblasts and may have a role in defining prostate cancer risk and skeletal metastases. METHODS. Conditioned media (CM) from human prostate cancer (PC), C4-2 and C4-2B, which produce osteoblastic lesions, and PC-3, which causes osteolysis, was added to MC3T3-E1 bone cultures. SCID mice were injected intratibially with these engineered cells. Tumor bearing tibiae were analyzed by microCT and pQCT. RESULTS. CM from PC cells increased osteoblast proliferation and differentiation and was unaltered by the type of PC cell, IGF-I antibodies, or exogenous IGF-I and IGFBP2. Study of intratibial PC tumors in SCID mice showed that C4-2 cells grew slowly preserving bone structure, while PC-3 tumors caused rapid osteolysis. Overexpression of IGF-I did not change either tumor progression or skeletal response. CONCLUSIONS. IGF-I is neither necessary nor sufficient for the osteoblastic response to PC metastases.

Original languageEnglish
Pages (from-to)789-800
Number of pages12
JournalProstate
Volume66
Issue number8
DOIs
Publication statusPublished - Jun 1 2006
Externally publishedYes

Fingerprint

Insulin-Like Growth Factor I
Cell Communication
Prostate
Prostatic Neoplasms
Carcinoma
Bone and Bones
Neoplasms
Osteolysis
SCID Mice
Conditioned Culture Medium
Osteoblasts
Neoplasm Metastasis
X-Ray Microtomography
In Vitro Techniques
Tibia
Intercellular Signaling Peptides and Proteins
Antibodies

Keywords

  • LNCaP
  • Osteoblast
  • Osteolysis
  • PC-3

ASJC Scopus subject areas

  • Urology

Cite this

IGF-I secretion by prostate carcinoma cells does not alter tumor-bone cell interactions in vitro or in vivo. / Rubin, Janet; Fan, Xian; Rahnert, Jill; Sen, Buer; Hsieh, Chia Ling; Murphy, Tamara C.; Nanes, Mark S.; Horton, Lindsay G.; Beamer, Wesley G.; Rosen, Clifford J.

In: Prostate, Vol. 66, No. 8, 01.06.2006, p. 789-800.

Research output: Contribution to journalArticle

Rubin, J, Fan, X, Rahnert, J, Sen, B, Hsieh, CL, Murphy, TC, Nanes, MS, Horton, LG, Beamer, WG & Rosen, CJ 2006, 'IGF-I secretion by prostate carcinoma cells does not alter tumor-bone cell interactions in vitro or in vivo', Prostate, vol. 66, no. 8, pp. 789-800. https://doi.org/10.1002/pros.20379
Rubin, Janet ; Fan, Xian ; Rahnert, Jill ; Sen, Buer ; Hsieh, Chia Ling ; Murphy, Tamara C. ; Nanes, Mark S. ; Horton, Lindsay G. ; Beamer, Wesley G. ; Rosen, Clifford J. / IGF-I secretion by prostate carcinoma cells does not alter tumor-bone cell interactions in vitro or in vivo. In: Prostate. 2006 ; Vol. 66, No. 8. pp. 789-800.
@article{9fa0d712165342c9ae9d95de029894d7,
title = "IGF-I secretion by prostate carcinoma cells does not alter tumor-bone cell interactions in vitro or in vivo",
abstract = "BACKGROUND. IGF-I is an important growth and differentiative factor for osteoblasts and may have a role in defining prostate cancer risk and skeletal metastases. METHODS. Conditioned media (CM) from human prostate cancer (PC), C4-2 and C4-2B, which produce osteoblastic lesions, and PC-3, which causes osteolysis, was added to MC3T3-E1 bone cultures. SCID mice were injected intratibially with these engineered cells. Tumor bearing tibiae were analyzed by microCT and pQCT. RESULTS. CM from PC cells increased osteoblast proliferation and differentiation and was unaltered by the type of PC cell, IGF-I antibodies, or exogenous IGF-I and IGFBP2. Study of intratibial PC tumors in SCID mice showed that C4-2 cells grew slowly preserving bone structure, while PC-3 tumors caused rapid osteolysis. Overexpression of IGF-I did not change either tumor progression or skeletal response. CONCLUSIONS. IGF-I is neither necessary nor sufficient for the osteoblastic response to PC metastases.",
keywords = "LNCaP, Osteoblast, Osteolysis, PC-3",
author = "Janet Rubin and Xian Fan and Jill Rahnert and Buer Sen and Hsieh, {Chia Ling} and Murphy, {Tamara C.} and Nanes, {Mark S.} and Horton, {Lindsay G.} and Beamer, {Wesley G.} and Rosen, {Clifford J.}",
year = "2006",
month = "6",
day = "1",
doi = "10.1002/pros.20379",
language = "English",
volume = "66",
pages = "789--800",
journal = "Prostate",
issn = "0270-4137",
publisher = "Wiley-Liss Inc.",
number = "8",

}

TY - JOUR

T1 - IGF-I secretion by prostate carcinoma cells does not alter tumor-bone cell interactions in vitro or in vivo

AU - Rubin, Janet

AU - Fan, Xian

AU - Rahnert, Jill

AU - Sen, Buer

AU - Hsieh, Chia Ling

AU - Murphy, Tamara C.

AU - Nanes, Mark S.

AU - Horton, Lindsay G.

AU - Beamer, Wesley G.

AU - Rosen, Clifford J.

PY - 2006/6/1

Y1 - 2006/6/1

N2 - BACKGROUND. IGF-I is an important growth and differentiative factor for osteoblasts and may have a role in defining prostate cancer risk and skeletal metastases. METHODS. Conditioned media (CM) from human prostate cancer (PC), C4-2 and C4-2B, which produce osteoblastic lesions, and PC-3, which causes osteolysis, was added to MC3T3-E1 bone cultures. SCID mice were injected intratibially with these engineered cells. Tumor bearing tibiae were analyzed by microCT and pQCT. RESULTS. CM from PC cells increased osteoblast proliferation and differentiation and was unaltered by the type of PC cell, IGF-I antibodies, or exogenous IGF-I and IGFBP2. Study of intratibial PC tumors in SCID mice showed that C4-2 cells grew slowly preserving bone structure, while PC-3 tumors caused rapid osteolysis. Overexpression of IGF-I did not change either tumor progression or skeletal response. CONCLUSIONS. IGF-I is neither necessary nor sufficient for the osteoblastic response to PC metastases.

AB - BACKGROUND. IGF-I is an important growth and differentiative factor for osteoblasts and may have a role in defining prostate cancer risk and skeletal metastases. METHODS. Conditioned media (CM) from human prostate cancer (PC), C4-2 and C4-2B, which produce osteoblastic lesions, and PC-3, which causes osteolysis, was added to MC3T3-E1 bone cultures. SCID mice were injected intratibially with these engineered cells. Tumor bearing tibiae were analyzed by microCT and pQCT. RESULTS. CM from PC cells increased osteoblast proliferation and differentiation and was unaltered by the type of PC cell, IGF-I antibodies, or exogenous IGF-I and IGFBP2. Study of intratibial PC tumors in SCID mice showed that C4-2 cells grew slowly preserving bone structure, while PC-3 tumors caused rapid osteolysis. Overexpression of IGF-I did not change either tumor progression or skeletal response. CONCLUSIONS. IGF-I is neither necessary nor sufficient for the osteoblastic response to PC metastases.

KW - LNCaP

KW - Osteoblast

KW - Osteolysis

KW - PC-3

UR - http://www.scopus.com/inward/record.url?scp=33646743621&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33646743621&partnerID=8YFLogxK

U2 - 10.1002/pros.20379

DO - 10.1002/pros.20379

M3 - Article

C2 - 16482567

AN - SCOPUS:33646743621

VL - 66

SP - 789

EP - 800

JO - Prostate

JF - Prostate

SN - 0270-4137

IS - 8

ER -